[1]
Syeda Shahmoona Tirmizi 2022. Efficacy of Secukinumab in Moderate to Severe Psoriasis Vulgaris: A Prospective Study. Pakistan Journal of Medical & Health Sciences. 16, 09 (Dec. 2022), 983. DOI:https://doi.org/10.53350/pjmhs22169983.